Cargando…
Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’
Autores principales: | von Rotz, Robin, Schindowski, Eva M., Jungwirth, Johannes, Schuldt, Anna, Rieser, Nathalie M., Zahoranszky, Katharina, Seifritz, Erich, Nowak, Albina, Nowak, Peter, Jäncke, Lutz, Preller, Katrin H., Vollenweider, Franz X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898017/ https://www.ncbi.nlm.nih.gov/pubmed/36747965 http://dx.doi.org/10.1016/j.eclinm.2023.101841 |
Ejemplares similares
-
Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial
por: von Rotz, Robin, et al.
Publicado: (2022) -
The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
por: Kraehenmann, Rainer, et al.
Publicado: (2015) -
Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences
por: Rieser, Nathalie M., et al.
Publicado: (2023) -
Effect of Psilocybin on Empathy and Moral Decision-Making
por: Pokorny, Thomas, et al.
Publicado: (2017) -
Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience
por: Lewis, Candace R., et al.
Publicado: (2020)